DukeMed Alumni News

A longtime advocate for the marriage of technology and data to advance health care, Amy Abernethy, MD’94, HS’94-’01, PhD, envisions a future in which the two are as ubiquitous and easy to use in the medical field as tongue depressors.

As the newly appointed principal deputy commissioner of the U.S. Food and Drug Administration (FDA)—the highest position at the FDA that is not a political appointment—Abernethy has a national platform in which to help advance personalized medicine.

From the day she took office as dean of Duke University School of Medicine in 2017, Mary E. Klotman, BS’76, MD’80, HS’80-’85, has advanced the idea of One Duke: the premise that the key to achieving great things lies in collaborations across Duke, regardless of title, unit, discipline, or any of the other labels that traditionally have compartmentalized the operations of a major academic medical institution.

The day her eyelashes froze together turned out to be a pivotal day for Heather Whitson, MD, HS’01-’04, ‘06. She was a medical school student at Cornell University at the time, spending the winter in Boston doing research with a Harvard geriatrician. She was enjoying the research so much she was hoping to do her residency at Harvard so she could continue it. But when her eyelashes froze, she started dreaming of warmer climes.

Dr. William G. Kaelin Jr., a Duke trustee and alumnus, was awarded the 2019 Nobel Prize for Physiology or Medicine. Kaelin received both his undergraduate and medical degrees from Duke and is a professor in the Department of Medicine at the Dana-Farber Cancer Institute at Harvard Medical School and a Howard Hughes Medical Institute investigator.

A team of 18 Duke staff, including a current Duke medical student and several DukeMed alumni, traveled to the Instituto Nacional Cardio-Pulmonar in Tegucigalpa, Honduras to perform heart surgeries. The hospital had nearly 100 patients on a waiting list for heart surgery, the majority were indigent patients with rheumatic valve disease.

For Andrew “Tip” Taylor, MD’68, the proverbial fountain of youth isn’t a fountain at all, but a river. Actually, lots of rivers.

For more than 40 years, Taylor—a renowned nuclear medicine physician and ambitious outdoor adventurer—and his friend Jim Slinger have connected for a yearly 3-to-4-week canoe and backpacking trip in northern Alaska and Canada. It’s not a casual undertaking: a bush plane deposits them in the remote wilderness, and until it returns to fetch them weeks later, they’re on their own in the wild, making their way through grizzly bear country.

Caroline Philpott, AB’83, MD’87 is a 2019 recipient of Duke Medical Alumni Association's Distinguished Alumna Award. She is one of the most respected international leaders in the biochemistry and cell biology of iron metabolism. She has made groundbreaking discoveries in iron metabolism that deciphered the human intracellular iron trafficking mechanism.

Welcome to the Revolution.

First came steam power, then electric power, and then the information age. Now, according to the World Economic Forum, we’re entering the Fourth Industrial Revolution, as the sciences converge around digitized information and data in ways that disrupt nearly every field in every country.

Michael Freemark, MD'76 is a 2019 recipient of Duke Medical Alumni Association's Distinguished Faculty Award. He is an internationally known pediatric endocrinologist who has made seminal discoveries in fields including obesity and childhood malnutrition, pediatric diabetes, intermediary metabolism, and the control of fetal growth. His basic science work has focused on the regulation of metabolism during pregnancy and its effects on fetal development. In clinical research, he has played a leading role in the field of pediatric nutrition.

With sepsis, time is of the essence. Left untreated, the illness—a runaway immune response to infection—can quickly become life-threatening. Hours, and even minutes, can mean the difference between life and death for this condition, which strikes more than 1.5 million people and kills more than 250,000 Americans each year.

Because sepsis is nonspecific, there is no single definitive sign, symptom, or test that identifies a patient as having it. That’s a huge challenge for providers, who need to assess patients as quickly as possible.